50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Burden of Total and Cause-Specific Mortality Related to Tobacco Smoking among Adults Aged ≥45 Years in Asia: A Pooled Analysis of 21 Cohorts

      research-article
      1 , 2 , 3 , * , 4 , 4 , 1 , 2 , 3 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 1 , 2 , 3 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 25 , 26 , 27 , 28 , 29 , 22 , 30 , 31 , 32 , 33 , 34 , 9 , 35 , 11 , 36 , 1 , 2 , 3 , 23 , 24 , 14 , 17 , 19 , 19 , 37 , 21 , 19 , 23 , 24 , 38 , 39 , 40 , 41 , 32 , 42 , 43 , 44 , 17 , 45 , 46 , 20 , 4 , 47 , 48 , 49 , 25 , 4
      PLoS Medicine
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Wei Zheng and colleagues quantify the burden of tobacco-smoking-related deaths for adults in Asia.

          Please see later in the article for the Editors' Summary

          Abstract

          Background

          Tobacco smoking is a major risk factor for many diseases. We sought to quantify the burden of tobacco-smoking-related deaths in Asia, in parts of which men's smoking prevalence is among the world's highest.

          Methods and Findings

          We performed pooled analyses of data from 1,049,929 participants in 21 cohorts in Asia to quantify the risks of total and cause-specific mortality associated with tobacco smoking using adjusted hazard ratios and their 95% confidence intervals. We then estimated smoking-related deaths among adults aged ≥45 y in 2004 in Bangladesh, India, mainland China, Japan, Republic of Korea, Singapore, and Taiwan—accounting for ∼71% of Asia's total population. An approximately 1.44-fold (95% CI = 1.37–1.51) and 1.48-fold (1.38–1.58) elevated risk of death from any cause was found in male and female ever-smokers, respectively. In 2004, active tobacco smoking accounted for approximately 15.8% (95% CI = 14.3%–17.2%) and 3.3% (2.6%–4.0%) of deaths, respectively, in men and women aged ≥45 y in the seven countries/regions combined, with a total number of estimated deaths of ∼1,575,500 (95% CI = 1,398,000–1,744,700). Among men, approximately 11.4%, 30.5%, and 19.8% of deaths due to cardiovascular diseases, cancer, and respiratory diseases, respectively, were attributable to tobacco smoking. Corresponding proportions for East Asian women were 3.7%, 4.6%, and 1.7%, respectively. The strongest association with tobacco smoking was found for lung cancer: a 3- to 4-fold elevated risk, accounting for 60.5% and 16.7% of lung cancer deaths, respectively, in Asian men and East Asian women aged ≥45 y.

          Conclusions

          Tobacco smoking is associated with a substantially elevated risk of mortality, accounting for approximately 2 million deaths in adults aged ≥45 y throughout Asia in 2004. It is likely that smoking-related deaths in Asia will continue to rise over the next few decades if no effective smoking control programs are implemented.

          Please see later in the article for the Editors' Summary

          Editors' Summary

          Background

          Every year, more than 5 million smokers die from tobacco-related diseases. Tobacco smoking is a major risk factor for cardiovascular disease (conditions that affect the heart and the circulation), respiratory disease (conditions that affect breathing), lung cancer, and several other types of cancer. All told, tobacco smoking kills up to half its users. The ongoing global “epidemic” of tobacco smoking and tobacco-related diseases initially affected people living in the US and other Western countries, where the prevalence of smoking (the proportion of the population that smokes) in men began to rise in the early 1900s, peaking in the 1960s. A similar epidemic occurred in women about 40 years later. Smoking-related deaths began to increase in the second half of the 20th century, and by the 1990s, tobacco smoking accounted for a third of all deaths and about half of cancer deaths among men in the US and other Western countries. More recently, increased awareness of the risks of smoking and the introduction of various tobacco control measures has led to a steady decline in tobacco use and in smoking-related diseases in many developed countries.

          Why Was This Study Done?

          Unfortunately, less well-developed tobacco control programs, inadequate public awareness of smoking risks, and tobacco company marketing have recently led to sharp increases in the prevalence of smoking in many low- and middle-income countries, particularly in Asia. More than 50% of men in many Asian countries are now smokers, about twice the prevalence in many Western countries, and more women in some Asian countries are smoking than previously. More than half of the world's billion smokers now live in Asia. However, little is known about the burden of tobacco-related mortality (deaths) in this region. In this study, the researchers quantify the risk of total and cause-specific mortality associated with tobacco use among adults aged 45 years or older by undertaking a pooled statistical analysis of data collected from 21 Asian cohorts (groups) about their smoking history and health.

          What Did the Researchers Do and Find?

          For their study, the researchers used data from more than 1 million participants enrolled in studies undertaken in Bangladesh, India, mainland China, Japan, the Republic of Korea, Singapore, and Taiwan (which together account for 71% of Asia's total population). Smoking prevalences among male and female participants were 65.1% and 7.1%, respectively. Compared with never-smokers, ever-smokers had a higher risk of death from any cause in pooled analyses of all the cohorts (adjusted hazard ratios [HRs] of 1.44 and 1.48 for men and women, respectively; an adjusted HR indicates how often an event occurs in one group compared to another group after adjustment for other characteristics that affect an individual's risk of the event). Compared with never smoking, ever smoking was associated with a higher risk of death due to cardiovascular disease, cancer (particularly lung cancer), and respiratory disease among Asian men and among East Asian women. Moreover, the researchers estimate that, in the countries included in this study, tobacco smoking accounted for 15.8% of all deaths among men and 3.3% of deaths among women in 2004—a total of about 1.5 million deaths, which scales up to 2 million deaths for the population of the whole of Asia. Notably, in 2004, tobacco smoking accounted for 60.5% of lung-cancer deaths among Asian men and 16.7% of lung-cancer deaths among East Asian women.

          What Do These Findings Mean?

          These findings provide strong evidence that tobacco smoking is associated with a substantially raised risk of death among adults aged 45 years or older throughout Asia. The association between smoking and mortality risk in Asia reported here is weaker than that previously reported for Western countries, possibly because widespread tobacco smoking started several decades later in most Asian countries than in Europe and North America and the deleterious effects of smoking take some years to become evident. The researchers note that certain limitations of their analysis are likely to affect the accuracy of its findings. For example, because no data were available to estimate the impact of secondhand smoke, the estimate of deaths attributable to smoking is likely to be an underestimate. However, the finding that nearly 45% of the global deaths from active tobacco smoking occur in Asia highlights the urgent need to implement comprehensive tobacco control programs in Asia to reduce the burden of tobacco-related disease.

          Additional Information

          Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001631.

          • The World Health Organization provides information about the dangers of tobacco (in several languages) and about the WHO Framework Convention on Tobacco Control, an international instrument for tobacco control that came into force in February 2005 and requires parties to implement a set of core tobacco control provisions including legislation to ban tobacco advertising and to increase tobacco taxes; its 2013 report on the global tobacco epidemic is available

          • The US Centers for Disease Control and Prevention provides detailed information about all aspects of smoking and tobacco use

          • The UK National Health Services Choices website provides information about the health risks associated with smoking

          • MedlinePlus has links to further information about the dangers of smoking (in English and Spanish)

          • SmokeFree, a website provided by the UK National Health Service, offers advice on quitting smoking and includes personal stories from people who have stopped smoking

          • Smokefree.gov, from the US National Cancer Institute, offers online tools and resources to help people quit smoking

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries.

          Exposure to second-hand smoke is common in many countries but the magnitude of the problem worldwide is poorly described. We aimed to estimate the worldwide exposure to second-hand smoke and its burden of disease in children and adult non-smokers in 2004. The burden of disease from second-hand smoke was estimated as deaths and disability-adjusted life-years (DALYs) for children and adult non-smokers. The calculations were based on disease-specific relative risk estimates and area-specific estimates of the proportion of people exposed to second-hand smoke, by comparative risk assessment methods, with data from 192 countries during 2004. Worldwide, 40% of children, 33% of male non-smokers, and 35% of female non-smokers were exposed to second-hand smoke in 2004. This exposure was estimated to have caused 379,000 deaths from ischaemic heart disease, 165,000 from lower respiratory infections, 36,900 from asthma, and 21,400 from lung cancer. 603,000 deaths were attributable to second-hand smoke in 2004, which was about 1·0% of worldwide mortality. 47% of deaths from second-hand smoke occurred in women, 28% in children, and 26% in men. DALYs lost because of exposure to second-hand smoke amounted to 10·9 million, which was about 0·7% of total worldwide burden of diseases in DALYs in 2004. 61% of DALYs were in children. The largest disease burdens were from lower respiratory infections in children younger than 5 years (5,939,000), ischaemic heart disease in adults (2,836,000), and asthma in adults (1,246,000) and children (651,000). These estimates of worldwide burden of disease attributable to second-hand smoke suggest that substantial health gains could be made by extending effective public health and clinical interventions to reduce passive smoking worldwide. Swedish National Board of Health and Welfare and Bloomberg Philanthropies. Copyright © 2011 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            21st-Century Hazards of Smoking and Benefits of Cessation in the United States

            Extrapolation from studies in the 1980s suggests that smoking causes 25% of deaths among women and men 35 to 69 years of age in the United States. Nationally representative measurements of the current risks of smoking and the benefits of cessation at various ages are unavailable. We obtained smoking and smoking-cessation histories from 113,752 women and 88,496 men 25 years of age or older who were interviewed between 1997 and 2004 in the U.S. National Health Interview Survey and related these data to the causes of deaths that occurred by December 31, 2006 (8236 deaths in women and 7479 in men). Hazard ratios for death among current smokers, as compared with those who had never smoked, were adjusted for age, educational level, adiposity, and alcohol consumption. For participants who were 25 to 79 years of age, the rate of death from any cause among current smokers was about three times that among those who had never smoked (hazard ratio for women, 3.0; 99% confidence interval [CI], 2.7 to 3.3; hazard ratio for men, 2.8; 99% CI, 2.4 to 3.1). Most of the excess mortality among smokers was due to neoplastic, vascular, respiratory, and other diseases that can be caused by smoking. The probability of surviving from 25 to 79 years of age was about twice as great in those who had never smoked as in current smokers (70% vs. 38% among women and 61% vs. 26% among men). Life expectancy was shortened by more than 10 years among the current smokers, as compared with those who had never smoked. Adults who had quit smoking at 25 to 34, 35 to 44, or 45 to 54 years of age gained about 10, 9, and 6 years of life, respectively, as compared with those who continued to smoke. Smokers lose at least one decade of life expectancy, as compared with those who have never smoked. Cessation before the age of 40 years reduces the risk of death associated with continued smoking by about 90%.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              50-year trends in smoking-related mortality in the United States.

              The disease risks from cigarette smoking increased in the United States over most of the 20th century, first among male smokers and later among female smokers. Whether these risks have continued to increase during the past 20 years is unclear. We measured temporal trends in mortality across three time periods (1959-1965, 1982-1988, and 2000-2010), comparing absolute and relative risks according to sex and self-reported smoking status in two historical cohort studies and in five pooled contemporary cohort studies, among participants who became 55 years of age or older during follow-up. For women who were current smokers, as compared with women who had never smoked, the relative risks of death from lung cancer were 2.73, 12.65, and 25.66 in the 1960s, 1980s, and contemporary cohorts, respectively; corresponding relative risks for male current smokers, as compared with men who had never smoked, were 12.22, 23.81, and 24.97. In the contemporary cohorts, male and female current smokers also had similar relative risks for death from chronic obstructive pulmonary disease (COPD) (25.61 for men and 22.35 for women), ischemic heart disease (2.50 for men and 2.86 for women), any type of stroke (1.92 for men and 2.10 for women), and all causes combined (2.80 for men and 2.76 for women). Mortality from COPD among male smokers continued to increase in the contemporary cohorts in nearly all the age groups represented in the study and within each stratum of duration and intensity of smoking. Among men 55 to 74 years of age and women 60 to 74 years of age, all-cause mortality was at least three times as high among current smokers as among those who had never smoked. Smoking cessation at any age dramatically reduced death rates. The risk of death from cigarette smoking continues to increase among women and the increased risks are now nearly identical for men and women, as compared with persons who have never smoked. Among men, the risks associated with smoking have plateaued at the high levels seen in the 1980s, except for a continuing, unexplained increase in mortality from COPD.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS Med
                PLoS
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, USA )
                1549-1277
                1549-1676
                April 2014
                22 April 2014
                : 11
                : 4
                : e1001631
                Affiliations
                [1 ]Division of Epidemiology, Department of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America
                [2 ]Vanderbilt Epidemiology Center, Vanderbilt University, Nashville, Tennessee, United States of America
                [3 ]Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, United States of America
                [4 ]Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
                [5 ]Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
                [6 ]The Tisch Cancer Institute, Ichan School of Medicine at Mount Sinai, New York, New York, United States of America
                [7 ]International Prevention Research Institute, Lyon, France
                [8 ]Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America
                [9 ]Healis-Sekhsaria Institute for Public Health, Navi Mumbai, India
                [10 ]Division of Radiation Oncology, Regional Cancer Center, Medical College Campus, Trivandrum, India
                [11 ]Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
                [12 ]Department of Health and Social Services, Ibaraki Prefectural Government, Ibaraki, Japan
                [13 ]Department of Public Health, Aichi Medical University School of Medicine, Aichi, Japan
                [14 ]Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
                [15 ]Duke–National University of Singapore Graduate Medical School, Singapore
                [16 ]Saw Swee Hock School of Public Health, National University of Singapore, Singapore
                [17 ]Radiation Effects Research Foundation, Hiroshima, Japan
                [18 ]Division of Epidemiology, Miyagi Cancer Center Research Institute, Natori, Japan
                [19 ]Tohoku University Graduate School of Medicine, Sendai, Japan
                [20 ]Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
                [21 ]Genomics Research Center, Academia Sinica, Taipei, Taiwan
                [22 ]Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
                [23 ]Division of Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America
                [24 ]Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
                [25 ]Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
                [26 ]Department of Health Studies, University of Chicago, Chicago, Illinois, United States of America
                [27 ]Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
                [28 ]Department of Human Genetics, University of Chicago, Chicago, Illinois, United States of America
                [29 ]University of Chicago Cancer Research Center, University of Chicago, Chicago, Illinois, United States of America
                [30 ]Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
                [31 ]Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan
                [32 ]Department of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Beijing, China
                [33 ]Fuwai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences, Beijing, China
                [34 ]China National Center for Cardiovascular Disease, Beijing, China
                [35 ]Screening Group, Prevention and Early Detection Section, International Agency for Research on Cancer, Lyon, France
                [36 ]Department of Public Health, Dokkyo Medical University School of Medicine, Tochigi, Japan
                [37 ]Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Science, Nagoya, Japan
                [38 ]Department of Social and Preventive Medicine, Hallym University College of Medicine, Okcheon-dong, Republic of Korea
                [39 ]Department of Preventive Medicine, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea
                [40 ]Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, United States of America
                [41 ]Division of Preventive Medicine and Health Services Research, Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan
                [42 ]Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
                [43 ]Graduate Institute of Environmental Science, China Medical University, Taichung, Taiwan
                [44 ]Department of Environmental Medicine, New York University School of Medicine, New York, New York, United States of America
                [45 ]Department of Food and Nutrition, Sookmyung Women's University, Seoul, Republic of Korea
                [46 ]Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, United States of America
                [47 ]Graduate School of Medicine, University of Tokyo, Tokyo, Japan
                [48 ]Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
                [49 ]Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
                San Diego State University, United States of America
                Author notes

                The authors have declared that no competing interests exist.

                Conceived and designed the experiments: WZ JDP. Performed the experiments: WZ JDP DFM BAR ZF MT ZF. Analyzed the data: DFM ZF MT ZF WZ. Contributed reagents/materials/analysis tools: WZ JH PCG KR ST FI AT YTG WPK XOS KO YN IT HT CJC JMY YOA KYY HA WHP YLQ DG MSP CS NS TS GY RW YBX WO MK TW IO SLY YS LMB DHK SKP FP SYC JHF CYS EJG JEL RS KM MI DK JDP. Wrote the first draft of the manuscript: WZ. Contributed to the writing of the manuscript: DFM PB YC EJG JEL RS MT ZF JDP. ICMJE criteria for authorship read and met: WZ DFM BAR ZF PB JH PCG KR ST FI AT YTG WPK XOS KO YN IT HT CJC JMY YOA KYY HA WHP YLQ DG MSP CS NS TS GY RW YBX WO MK TW IO SLY YS LMB DHK SKP FP SYC JHF CYS YC EJG JEL RS KM MT MI ZF DK JDP. Agree with manuscript results and conclusions: WZ DFM BAR ZF PB JH PCG KR ST FI AT YTG WPK XOS KO YN IT HT CJC JMY YOA KYY HA WHP YLQ DG MSP CS NS TS GY RW YBX WO MK TW IO SLY YS LMB DHK SKP FP SYC JHF CYS YC EJG JEL RS KM MT MI ZF DK JDP. Enrolled patients:WZ JH PCG KR ST FI AT YTG WPK XOS KO YN IT HT CJC JMY YOA KYY HA WHP YLQ DG MSP CS NS TS GY RW YBX WO MK TW IO SLY YS LMB DHK SKP FP SYC JHF CYS EJG JEL RS KM MI DK JDP.

                Article
                PMEDICINE-D-13-02950
                10.1371/journal.pmed.1001631
                3995657
                24756146
                62add607-9619-447a-80d5-2551744f4d53
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 12 September 2013
                : 7 March 2014
                Page count
                Pages: 15
                Funding
                Participating cohort studies (funding sources) in the consortium are: Mumbai Cohort Study (Mumbai, funding sources: International Agency for Research on Cancer, Clinical Trials Service Unit/Oxford University, World Health Organization); Trivandrum Oral Cancer Screening (TOCS) Trial (funding sources: Association for International Cancer Research, St Andrews, UK; and Cancer Research UK); Health Effects of Arsenic Longitudinal Study [Bangladesh, funding sources: NIH (P42ES010349, R01CA102484, R01CA107431)]; China National Hypertension Survey Epidemiology Follow-up Study [CHEFS, funding sources: American Heart Association (9750612N), NHLBI (U01-HL072507), Chinese Academy of Medical Sciences]; Shanghai Cohort Study [SCS, funding sources: NIH (R01CA0403092, R01CA144034)]; Shanghai Men's Health Study [SMHS, funding sources: NIH (R01-CA82729)]; Shanghai Women's Health Study [SWHS, funding sources: NIH (R37-CA70867)]; Community-Based Cancer Screening Project [CBCSP, funding sources: National Science Council and Department of Health, Taiwan]; CardioVascular Disease risk FACtor Two-township Study [CVDFACTS, funding sources: Department of Health, Taiwan (DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, and DOH84-TD-006)]; Singapore Chinese Health Study [SCHS, funding sources: NIH (R01CA55069, R35CA53890, R01CA80205, R01CA144034)]; and Korea Multi-center Cancer Cohort [KMCC, funding sources: Ministry of Education, Science and Technology, Korea (2009-0087452), National Research Foundation of Korea (2009-0087452)]. The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan is a private, nonprofit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the U.S. Department of Energy (DOE), the latter in part through DOE Award DE-HS0000031 to the National Academy of Sciences. This publication was supported by RERF Research Protocol RP-A03-10. Other Japanese cohorts: Three Prefecture Cohort Study Aichi (3-Prefecture Aichi); Ibaraki Prefectural Health Study (JACC); Japan Public Health Center-based Prospective Study (JPHC1, JPHC2); Three Prefecture Cohort Study Miyagi (3-Prefecture Miyagi); Miyagi Cohort Study (Miyagi); and Ohsaki National Health Insurance Cohort Study (Ohsaki), are supported by the Grantin-aid for Cancer Research, the Grant for the Third Term Comprehensive Control Research for Cancer, the Grant for Health Services, the Grant for Medical Services for Aged and Health Promotion, the Grant for Comprehensive Research on Cardiovascular and Life-style Related Diseases from the Ministry of Health, Labour and Welfare, Japan, and the Grant for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Japan Public Health Center-Based Prospective Study is also supported by the National Cancer Center Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Medicine and Health Sciences
                Epidemiology
                Environmental Epidemiology

                Medicine
                Medicine

                Comments

                Comment on this article